W. S. McCool

Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist.

Duane D. Miller, James I. Fells, Y. Fujiwara, 2015, Chemistry & biology.

Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA 2 Receptor-Specific Nonlipid Agonist Graphical

Duane D. Miller, James I. Fells, Y. Fujiwara, 2015 .

Mitigation of the Hematopoietic and Gastrointestinal Acute Radiation Syndrome by Octadecenyl Thiophosphate, a Small Molecule Mimic of Lysophosphatidic Acid

Duane D. Miller, L. Johnson, G. Tigyi, 2015, Radiation research.

Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential

L. Johnson, G. Tigyi, A. Balogh, 2019, Journal of Lipid Research.